118 related articles for article (PubMed ID: 3937179)
21. Basic aggregation properties of washed rat platelets: correlation between aggregation, phospholipid degradation, malondialdehyde, and thromboxane formation.
Tomita T; Umegaki K; Hayashi E
J Pharmacol Methods; 1983 Aug; 10(1):31-44. PubMed ID: 6632921
[TBL] [Abstract][Full Text] [Related]
22. Metabolism of arachidonic acid by macaque platelets. Implications for studies on atherosclerosis.
Beatty CH; Howard CF; Hoskins MK; Herrington PT
Atherosclerosis; 1985 Apr; 55(1):1-13. PubMed ID: 3924062
[TBL] [Abstract][Full Text] [Related]
23. The influence of PAF on the metabolization of arachidonic acid by human blood platelets.
Ostermann G; Block HU; Till U
Biomed Biochim Acta; 1984; 43(8-9):S323-6. PubMed ID: 6440547
[TBL] [Abstract][Full Text] [Related]
24. [Observations on levels of TXA2 and PGI2 and the generation of platelet MDA in patients with chronic cor pulmonale].
Zhou YC
Zhonghua Jie He He Hu Xi Za Zhi; 1987 Apr; 10(2):80-2, 123-4. PubMed ID: 3319212
[No Abstract] [Full Text] [Related]
25. Effect of some vasodilating and antihypertensive drugs on the in vitro biosynthesis of prostaglandins from (1-14C) arachidonic acid in washed human blood platelets.
Srivastava KC; Awasthi KK
Prostaglandins Leukot Med; 1982 Apr; 8(4):317-33. PubMed ID: 6810381
[TBL] [Abstract][Full Text] [Related]
26. Malondialdehyde formation in rat platelet-rich plasma. I.A kinetic approach.
Rajtar G; Livio M; Merino J; de Gaetano G
Thromb Haemost; 1980 Oct; 44(2):49-51. PubMed ID: 7455990
[TBL] [Abstract][Full Text] [Related]
27. Vinca alkaloids inhibit conversion of arachidonic acid to thromboxane by human platelet microsomes: comparison with other microtubule-active drugs.
Maguire MH; Csonka-Khalifah L
Biochim Biophys Acta; 1987 Oct; 921(3):426-36. PubMed ID: 3117116
[TBL] [Abstract][Full Text] [Related]
28. Kinetic studies on the conversion of prostaglandin endoperoxide PGH2 by thromboxane synthase.
Anderson MW; Crutchley DJ; Tainer BE; Eling TE
Prostaglandins; 1978 Oct; 16(4):563-70. PubMed ID: 725086
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory action of soluble elastin on thromboxane B2 formation in blood platelets.
Sekiya K; Okuda H
Biochim Biophys Acta; 1984 Mar; 797(3):348-53. PubMed ID: 6320905
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of platelet thromboxane synthetase by L-1-tosylamido-2-phenylethyl chloromethyl ketone.
Yahn DM; Feinstein MB
Prostaglandins; 1981 Feb; 21(2):243-54. PubMed ID: 7194491
[TBL] [Abstract][Full Text] [Related]
31. The association of in vitro arachidonic acid responsiveness and plasma thromboxane levels with early platelet deposition on the luminal surface of small-diameter grafts.
Freeman MB; Sicard GA; Valentin LI; Neuberger S; Mangino MJ; Anderson CB
J Vasc Surg; 1988 Apr; 7(4):554-61. PubMed ID: 3127601
[TBL] [Abstract][Full Text] [Related]
32. p-Aminobenzoic acid, but not its metabolite p-acetamidobenzoic acid, inhibits thrombin induced thromboxane formation in human platelets in a non NSAID like manner.
Barbieri B; Papadogiannakis N; Eneroth P; Söderstedt A; Stain-Malmgren R; Olding LB
Thromb Res; 1997 Apr; 86(2):127-40. PubMed ID: 9175234
[TBL] [Abstract][Full Text] [Related]
33. Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment.
Temperilli F; Rina A; Massimi I; Montemari AL; Guarino ML; Zicari A; Pulcinelli FM
Platelets; 2015; 26(8):783-7. PubMed ID: 25734355
[TBL] [Abstract][Full Text] [Related]
34. Fish oil fatty acids and human platelets: dose-dependent decrease in dienoic and increase in trienoic thromboxane generation.
Krämer HJ; Stevens J; Grimminger F; Seeger W
Biochem Pharmacol; 1996 Oct; 52(8):1211-7. PubMed ID: 8937428
[TBL] [Abstract][Full Text] [Related]
35. Effect of cetiedil on platelet aggregation and thromboxane synthesis.
Yamaguchi A; Asakura T; Tanoue K; Yamazaki H
Thromb Res; 1985 Feb; 37(3):391-400. PubMed ID: 2986312
[TBL] [Abstract][Full Text] [Related]
36. Platelet malondialdehyde production kinetics after cyclooxygenase block. A study performed with a modified high sensitivity assay.
Nenci GG; Parise P; Capodicasa E; Berrettini M
Haemostasis; 1983; 13(1):53-60. PubMed ID: 6404715
[TBL] [Abstract][Full Text] [Related]
37. Thromboxane a2: biosynthesis and effects on platelets.
Granström E; Diczfalusy U; Hamberg M; Hansson G; Malmsten C; Samuelsson B
Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():15-58. PubMed ID: 6216781
[No Abstract] [Full Text] [Related]
38. Glutathione disulfide production during arachidonic acid oxygenation in human platelets.
Burch JW; Burch PT
Prostaglandins; 1990 Feb; 39(2):123-34. PubMed ID: 2107565
[TBL] [Abstract][Full Text] [Related]
39. Spectrofluorimetric quantification of malondialdehyde for evaluation of cyclooxygenase-1/thromboxane synthase inhibition.
Dannhardt G; Flemmer L; Hartmann RW; Kleber A; Schulze E
Arch Pharm (Weinheim); 1998 Nov; 331(11):359-64. PubMed ID: 9881059
[TBL] [Abstract][Full Text] [Related]
40. Activity of dipyrone on intraplatelet arachidonic acid metabolism: an in vitro study.
Abbate R; Pinto S; Gori AM; Paniccia R; Coppo M; Neri Serneri GG
Pharmacol Res; 1989; 21(1):43-50. PubMed ID: 2726664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
